Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Electrophoresis System

By Drug Discovery Trends Editor | February 18, 2008

Shimadzu’s MCE-202 MultiNA with reusable microchips automates sample processing for DNA and RNA nucleic acid, including pre-treatment, separation, detection, and data preparation, in a single device. An LED-excited fluorescence detector increases sensitivity to more than 10 times that of ethidium bromide staining, yet operating costs for this unit are comparable to or less than agarose gel electrophoresis and 25 percent less than equivalent-class microchip systems, according to the company.

The MultiNA system can register up to 120 analysis cycles, and perform efficient analysis from just one sample. By parallel processing up to four microchips, it can produce pretreatment and electrophoresis results in just 75 seconds.

The MultiNA is automatic with high-speed analysis, simple operability, high separation, and high repeatability. It uses reagent kits that correspond to separation size, automatically injecting a set quantity of reagent so it uses small amounts of important samples (as little as 2 ?L) and high-cost reagents. Simultaneous electrophoresis of an internal marker ensures analysis reliability and reproducibility.

Shimadzu’s software for the MultiNA uses size markers to automatically correct electrophoresis results for size prediction and quantitation. Users can perform either automatic or manual data analysis, and confirm completed results even as other sample analysis continues. The software includes a well status display, analysis schedule list and chip status display for current operating status.

www.ssi.shimadzu.com

See Shimaduz’s MCE-202 MultiNA at Pittcon, Booth 3755.

 


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

DNA Script SYNTAX
DNA Script raises $165M Series C for DNA printing platform
DNA Script SYNTAX
DNA Script launches a benchtop DNA printer
DNA
Unraveling the promise of genetics for treating progressive illness 
Alzheimer's disease
How to build a foundation for the next phase of Alzheimer’s disease research

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50